Published in:
01-02-2014 | Article
The role of the transcription factor ETV5 in insulin exocytosis
Authors:
Ruth Gutierrez-Aguilar, Dong-Hoon Kim, Marina Casimir, Xiao-Qing Dai, Paul T. Pfluger, Jongsun Park, April Haller, Elizabeth Donelan, Jisoo Park, David D’Alessio, Stephen C. Woods, Patrick E. MacDonald, Randy J. Seeley
Published in:
Diabetologia
|
Issue 2/2014
Login to get access
Abstract
Aims/hypothesis
Genome-wide association studies have revealed an association of the transcription factor ETS variant gene 5 (ETV5) with human obesity. However, its role in glucose homeostasis and energy balance is unknown.
Methods
Etv5 knockout (KO) mice were monitored weekly for body weight (BW) and food intake. Body composition was measured at 8 and 16 weeks of age. Glucose metabolism was studied, and glucose-stimulated insulin secretion was measured in vivo and in vitro.
Results
Etv5 KO mice are smaller and leaner, and have a reduced BW and lower fat mass than their wild-type controls on a chow diet. When exposed to a high-fat diet, KO mice are resistant to diet-induced BW gain. Despite a greater insulin sensitivity, KO mice have profoundly impaired glucose tolerance associated with impaired insulin secretion. Morphometric analysis revealed smaller islets and a reduced beta cell size in the pancreatic islets of Etv5 KO mice. Knockdown of ETV5 in an insulin-secreting cell line or beta cells from human donors revealed intact mitochondrial and Ca2+ channel activity, but reduced insulin exocytosis.
Conclusion/interpretation
This work reveals a critical role for ETV5 in specifically regulating insulin secretion both in vitro and in vivo.